Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Postmeiotic segregation increased 2 pseudogene 5" (PMS2P5, ENSG00000304176) is a non-coding RNA or pseudogene that is antisense to SPDYE12. It is classified as a member of the PMS2 gene family, which is best known for its role in DNA mismatch repair via the canonical PMS2 protein. However, unlike PMS2, PMS2P5 is not known to produce a functional protein and has no established role in DNA repair or any other cellular process. Its annotation as a "novel transcript, antisense to SPDYE12" reflects its genomic location rather than functional significance. There is no evidence that this gene acts as a therapeutic target, nor is there any information linking it to direct drug interactions, disease associations, or functional protein activities[5][7]. Summary: ENSG00000304176 (PMS2P5) is a non-functional pseudogene with no established therapeutic, enzymatic, or receptor activity. It should not be considered a drug target. Its primary significance is as a genomic element related to the PMS2 and SPDYE12 gene regions[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Postmeiotic segregation increased 2 pseudogene 5 (PMS2P5).